Legalization Biden hasn’t fulfilled cannabis promises, most Americans don’t think he will Advocates and citizens have little hope for drug policy reform from the Biden administration this year Kathryn TindaleJanuary 20, 2022
International Thailand removing cannabis from narcotics list, paving way to decriminalize pot But the country's piecemeal approach to reforming drug laws are causing confusion Kathryn TindaleJanuary 19, 2022
Business BC Chamber of Commerce calls to cut red tape for cannabis industry Freeing up legal operators will boost economic activity and consumer safety, industry representatives say Nick LabaJanuary 18, 2022
International France’s National Assembly rejects cannabis legalization bill The lower house of parliament didn't adopt the bill, which was expected Kathryn TindaleJanuary 14, 2022
International Italian court certifies signatures to trigger cannabis referendum The Constitutional Court still needs to issue an opinion and set a date for the vote, which advocates hope could come as early as... Kathryn TindaleJanuary 13, 2022
Business Victoria trims cannabis retail fees City council voted Thursday to reduce the licensing fee to $3,500 in 2022 from $5,000 previously Nick LabaJanuary 13, 2022
Hemp Portugal defines new rules for industrial hemp cultivation The amendment is meant to address insufficient regulations Kathryn TindaleJanuary 11, 2022
Canada What amendments to Canada’s restricted drug program mean for patients and practitioners The new rules will facilitate safer access to substances like psilocybin, but many in need won't qualify, experts say Natalia Buendia CalvilloJanuary 11, 2022
Canada Health Canada to host diversity forum for cannabis licensing Despite ongoing calls, no social equity provisions have yet to be included in the country's cannabis regulations Nick LabaJanuary 10, 2022
Canada Study warning of post-legalization pot poisonings doesn’t control for illicit products The research shows a sharp uptick in young children going to hospital, in the period after legal edibles came to market Natalia Buendia CalvilloJanuary 7, 2022